|
|
| |
| Most Discussed Stocks |
 |
|
|
|
| |
|
News |
| |
|
WILL THE FDA GIVE THE GREEN LIGHT T.... |
10/06/2008 |
|
Has the time come for Provenge, the prostate cancer vaccine developed by Dendreon, to be given marketing approval so it can save condemned metastatic prostate cancer patients’ lives? |
| |
|
PROGENICS: THE HIV DRUG LOOKS PROMI.... |
10/02/2008 |
|
|
| |
|
WE WILL BE ALL RIGHT |
09/25/2008 |
|
We gave you Sequenom and many other winners. Prohost will continue to do the same, hopefully without as much struggling against the greed of those who took advantage of the market deregulation to turn it into a vehicle for self-fulfillment of destructive prophesies at the expense of the serious investors.
We surely believe that America is capable of overcoming this crisis. Yet, our hope is in a reform that stops the greed that tarnished the market’s and America’s strong economy’s reputation.
We will be all right.
|
| |
|
SEQUENOM (SQNM): SUCCESS OF NON INV.... |
09/24/2008 |
|
The results are 100% without manipulation of the fetus and with a simple mother\'s blood test. |
| |
|
CYTRX COMPLETES ITS BUYOUT OF INNOV.... |
09/23/2008 |
|
Cytrx inherited the cancer drug tamibarotene, which has been approved in Japan for acute promyelocytic leukemia (APL). It also inherited three other drug candidates. Read about tamibarotene. Read also about the a stool test that shows successful results in diagnosing colorectal cancer. |
| |
|
|
| |
| |
| |
|
|
Stocks >> Stocks Details |
|
|
| |
|
INFECTION, INFLAMMATION AND MALIGNANCY |
|
|
|
ADVANCED LIFE SCIENCES HOLDINGS, INC.,
|
| |
|
Advanced Life Sciences is a development stage
biopharmaceutical company that engages in the discovery and development of drugs
for infectious disease, inflammation, and oncology. It has an exclusive
worldwide license from Abbott Laboratories to develop and
commercialize cethromycin, a
ketolide antibiotic in Phase 3 clinical development for the treatment of
respiratory tract infections.
The company also develops ALS-886, a
therapeutic in preclinical development for the treatment of inflammation-related
tissue damage, including tissue damage associated with acute respiratory
distress syndrome; ALS-357, a compound that has shown evidence of
anti-tumor activity against malignant melanoma in preclinical studies.
Advanced Life Sciences Holdings’ also develops additional product candidates
that include compounds derived from natural products to treat infectious
diseases; a class of synthetic chemotherapeutics to treat various cancers and small molecule inhibitors for the treatment of Alzheimer’s disease.
The firm has a 50% joint venture interest in Sarawak MediChem Pharmaceuticals,
Inc. Advanced Life Sciences was founded by Michael T. Flavin in 1999 and is based in Woodridge,
Illinois.
|
| |
| |
| |
| |
| |
| |
|
|
|
|
